Form 8-K - Current report:
SEC Accession No. 0001144204-11-043025
Filing Date
2011-08-01
Accepted
2011-08-01 09:00:26
Documents
2
Period of Report
2011-08-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v230369_8k.htm 8-K 27973
2 v230369_ex99-1.htm EX-99.1 17744
  Complete submission text file 0001144204-11-043025.txt   47045
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 11999136
SIC: 2836 Biological Products, (No Diagnostic Substances)